Janney Montgomery Scott’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-66,993
Closed -$1.3M 2718
2025
Q1
$1.3M Buy
66,993
+506
+0.8% +$10.7K ﹤0.01% 1387
2024
Q4
$1.47M Buy
66,487
+15,332
+30% +$295K ﹤0.01% 1326
2024
Q3
$861K Buy
51,155
+3,912
+8% +$58K ﹤0.01% 1606
2024
Q2
$565K Buy
47,243
+1,943
+4% +$21.7K ﹤0.01% 1801
2024
Q1
$502K Buy
45,300
+31,981
+240% +$326K ﹤0.01% 2000
2023
Q4
$115K Buy
+13,319
New +$104K ﹤0.01% 2539

Other funds holding CLBT

Janney Montgomery Scott's CLBT Position: Q2 2025 in Review

Janney Montgomery Scott sold out of Cellebrite (CLBT) in Q2 2025, closing a stake of 66,993 shares — an estimated $1.3M sold.

Janney Montgomery Scott first reported a position in CLBT in Q4 2023 and held it in 6 quarters. The position peaked at $1.47M in Q4 2024. 209 funds tracked by Wall St. Rank hold CLBT as of Q2 2025.

  • Janney Montgomery Scott reported no remaining Cellebrite position as of Q2 2025 after selling out during the quarter.
  • Janney Montgomery Scott sold 66,993 Cellebrite shares in Q2 2025, an estimated $1.3M.
  • Janney Montgomery Scott first reported a position in Cellebrite in Q4 2023 and held it in 6 quarters.
  • Janney Montgomery Scott's Cellebrite position peaked at $1.47M in Q4 2024.
  • 209 funds tracked by Wall St. Rank held Cellebrite as of Q2 2025.

Based on Janney Montgomery Scott's 13F filing for Q2 2025, filed 17 Jul 2025.